Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSuperseed Capital Limited Regulatory News (WWW.PL)

Share Price Information for Superseed Capital Limited (WWW.PL)

Share Price is delayed by 15 minutes
Get Live Data
75.00    0.00 (0.00%)
Bid:
65.00
Ask:
85.00
Spread: 20.00 (30.769%)
Market Cap: £1.77m
WWW.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Superseed Capital Limited Share Chart

Q4 2025 Results

13 Feb 2026 07:00

RNS Number : 8290S
SuperSeed Capital Limited
13 February 2026
 

SUPERSEED CAPITAL LIMITED

(the "Company")

 

UNAUDITED FOURTH QUARTER 2025 RESULTS

 

 

SuperSeed Capital Limited, a company established as a venture capital fund of funds for early-stage AI/SaaS companies, announces unaudited results for Q4 2025 and the year ending 31 December 2025. The Company invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures LLP (the "Investment Manager"). The Company's principal investment to date is in SuperSeed II LP (the "Fund").

 

 

Financial Highlights for Q4 2025:

· NAV per share has increased by 12p during the quarter, now at £1.33 per share on a fully diluted basis, which also represents a 12p increase from 31 December 2024.

· A total of £238,511 was invested in Fund portfolio investments in the period.

 

 

Fund Portfolio and Investment Highlights:

· Fund portfolio revenue grew at nearly 100% annualised in Q4 2025.

· Two new companies were added to the Fund portfolio in Q4 2025 (Hive Autonomy and SOLVE Chemistry), with a further two investments completing in Q1 2026 (Cursive and All3).

 

 

Outlook for 2026:

· The Fund's investment period has now ended.

· Several companies in the Fund's portfolio are progressing towards Series A, with significant activity expected in H1 2026.

 

 

Mads Jensen, Managing Partner of the Investment Manager, commented:

 

"The Fund portfolio's performance continues to track top-performing VC fund benchmarks globally. Q4 2025 was another strong quarter for the Fund's portfolio, with several companies hitting new valuation milestones and progressing towards major funding rounds. This is expected to drive substantial TVPI expansion in the quarters to come as valuations reflect continued portfolio progress."

 

 

For more information, please contact:

 

SuperSeed Capital Limited

+44(0) 203 405 3060

Mads Jensen, Investment Manager

 

VSA Capital - AQSE Corporate Adviser and Broker

+44(0) 203 005 5000

Corporate Finance: Andrew Raca / Dylan Sadie

 

 

About SuperSeed Capital Limited

SuperSeed exists to back Europe's best B2B SaaS founders at the earliest stages and to help them build great companies. In the short term, our portfolio companies enable their customers to drive revenue growth and efficiency savings using next-generation software and AI. In the long-term, they have an opportunity to create category defining global technology companies. SuperSeed focuses on the fundamentals by helping founders build good companies with strong unit economics and sensible distribution models.

 

 

Forward-looking statements

This announcement contains statements that are or may be forward-looking statements. All statements other than statements of historical facts included in this announcement may be forward-looking statements, including statements that relate to the Company's future prospects, developments and strategies. The Company does not accept any responsibility for the accuracy or completeness of any information reported by the press or other media, nor the fairness or appropriateness of any forecasts, views or opinions expressed by the press or other media regarding the Group. The Company makes no representation as to the appropriateness, accuracy, completeness or reliability of any such information or publication.

 

Forward-looking statements are identified by their use of terms and phrases such as "believe", "targets", "expects", "aim", "anticipate", "projects", "would", "could", "envisage", "estimate", "intend", "may", "plan", "will" or the negative of those, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from those expressed or implied by such forward looking statements include, but are not limited to, those described in the Risk Management Framework section of the Company's most recent Annual Report. These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of the Group and the environment in which it is and will operate in the future. All subsequent oral or written forward-looking statements attributed to the Company or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. Each forward-looking statement speaks only as at the date of this announcement. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither the Company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Investment Manager's Review

 

The Capability Constraint is Over

The technical community has been using Claude Code for a year. It's an agent harness that enables Claude to execute your instructions: not just answering questions, but taking actions on your computer, connecting to data sources, accomplishing objectives. Originally built for writing code, it now works for marketing, email processing, research, and everything else.

 

Three things happened in January that changed the game:

 

First, Anthropic released CoWork. This puts Claude Code-like capabilities in the hands of everyone, not just developers. There's been a sudden realisation of just how powerful the agentic way of working is, and now anyone can access it.

 

Second, the OpenClaw project takes the approach further. Claude Code is still "give me a prompt, go do actions, come back with results." OpenClaw is "here are my objectives for the world, go figure out how to achieve them, even if it takes hours, days, or weeks." You could ask it to produce a podcast: research guests, contact them, create background research, book them in your calendar, reply to their emails, reach out on WhatsApp. Anything you can accomplish through a computer; the agent can try to do. That doesn't mean it will succeed. And many people have trepidation about giving an agent full access to their email, WhatsApp, passwords, everything. But this is the agentic future, and we've just seen a powerful glimpse of it.

 

Third, China's Moonshot released Kimi K2.5, an open source model that is comparable to Anthropic's Opus 4.6 at agentic work. It's built for parallelisation: spinning up a hundred agents to run simultaneously, all orchestrated by one model. Match that with the OpenClaw harness and you can see how powerful this becomes.

 

The capability constraint is over. The models are here. The harnesses work. And yet 95% of enterprise AI projects still fail to reach production.

 

The Real Bottleneck

The failure isn't technical. MIT's 2025 research found the top obstacles are data quality (43%), lack of technical maturity (43%), and skills shortage (35%). S&P Global reports 42% of companies now abandon AI initiatives before production, up from 17% the previous year.

 

Enterprises have access to powerful models but lack the infrastructure to deploy them. The constraint has shifted from "can we build AI that does this?" to "can we tell if AI did it correctly?".

 

Software development transformed first, but not because we have systems to check AI output today. It's because the models were trained on those systems. During training, models learned from test suites via reinforcement learning. They got fast feedback on what works and what doesn't. Software has right and wrong answers, unlike so many other fields. The models were beaten into perfection by having first-class, fast feedback during training.

 

Other sectors lack this training infrastructure. Institutional knowledge lives in people's heads and dies when they leave. Decision logic sits in spreadsheets no one maintains. There's no equivalent of a test suite to train models against, because those verification systems were never built.

 

Where Value Concentrates

We've written before about the broken economics of AI infrastructure. A $30/month Cursor subscription flows entirely to Anthropic, who loses money on every transaction paying hyperscalers, who lose money funding the frontier labs who buy their chips. Only NVIDIA profits. The funding loop masks dysfunction at every layer.

 

As these economics resolve (inference costs collapsing, open-source matching proprietary at one-tenth the price), value will migrate up the stack. The PC era shifted value from hardware to software. The internet era shifted value from infrastructure to applications. The AI era will shift value from model providers to those who make AI deployable.

 

The winning companies won't build bigger models. They'll build applications that unlock sector-specific value, with the decision scaffolding and verification that makes AI outputs trustworthy.

 

This is where the Fund's portfolio sits.

 

 

Q4 2025 Fund Portfolio Performance

While the industry debates whether the AI bubble will burst, the Fund's portfolio companies are building applications that transform specific industries. They encode domain expertise, verification systems, and decision infrastructure into software that makes AI actually work.

 

Fund Metrics

Q4 was the strongest quarter to date, capping 2025 as a strong year:

 

· Net IRR: 21.1%

· TVPI: 1.25x

· DPI: 0.13x

· Portfolio CARR: $22 million (up 69% from $13 million at start of 2025)

 

Fund portfolio revenue grew at nearly 100% annualised in Q4.

 

Over four years, the Fund has delivered 21.1% net IRR compared to 10.6% annualised from holding the S&P 500 (49.4% total return for the S&P 500 over the period). As the Fund's portfolio matures and companies progress through subsequent funding rounds, we expect continued outperformance.

 

Investment Period Complete

After four years, the Fund's investment period is complete. The Fund has built a portfolio of 27 companies, each applying AI to transform specific sectors.

 

The timing matters. The Fund began deploying in January 2022, nearly a year before the release of ChatGPT. It invested through the generative AI revolution, watching capabilities explode while deployment remained stubbornly difficult. Now, as the Fund closes its investment period, the industry is finally grappling with the gap between what AI can do and what organisations can verify.

 

New Investments

Q4 saw two new investments for the Fund, with two more closing in early Q1 2026:

 

Hive Autonomy is a universal platform for remote and autonomous operation of any industrial vehicle. One operator can control multiple machines simultaneously from a centralised station. Removes workers from dangerous environments, improves productivity. Forklifts, excavators, diggers. These machines move trillions of pounds of materials globally and operate exactly as they did fifty years ago.

 

SOLVE Chemistry combines automated high-throughput flow chemistry with machine learning. They compress pharmaceutical process development from 9-24 months to weeks, generating 20x more data than traditional methods. Already working with BASF, AstraZeneca, and Hovione.

 

In early Q1 2026, the Fund completed investments in Cursive (a DeepMind spin-out working on real-time generative AI models, still in stealth) and All3 (construction technology extending our Physical AI thesis into one of the world's largest and least digitised industries).

 

Portfolio Spotlight: Physical AI

Three of the Fund's investment portfolio companies show where AI creates defensible value in the physical world:

 

Hive solves implementation where traditional automation fails. Unlike AGVs requiring controlled environments and fixed paths, Hive's AI operates in unpredictable conditions: active warehouses, construction sites, industrial facilities. Every site differs. The expertise isn't in the model. It's making autonomy work where scripted automation breaks down.

 

OctaiPipe now has ABB as both investor and distribution partner. ABB offers a strong distribution channel for Octaipipe.

 

All3 applies similar logic to construction. Paper processes, tribal knowledge, and manual coordination waste billions annually. The decision infrastructure that makes AI deployable in construction looks nothing like what works in software. All3 is building it.

 

Looking Forward

Several of the Fund's investment portfolio companies are progressing toward Series A. We expect significant activity in H1 2026.

 

The AI revolution accelerates. Models grow more powerful weekly. Open source narrows the gap with proprietary systems. Agentic architectures mature from research to production.

 

But capability was never the constraint. The companies that win will build applications that make AI actually deployable in specific sectors, with the domain expertise and verification that transforms powerful models into trustworthy software.

 

That's what we built the Fund's portfolio to do.

 

 

Related Party Transactions

 

Convertible Loan Note Instrument

Further to the announcement made on 26 June 2024, the Company is pleased to announce it has extended the duration of the loan facility, for the issue of convertible loan notes (the "Convertible Loan Notes") to the Investment Manager. As and when issued in the future, the proceeds of the Convertible Loan Notes shall be used to fund the Company's short-term working capital and capital expenditure requirements.

 

The Convertible Loan Note instrument has been amended such that: 1) the aggregate principal amount of the Notes outstanding at any time has been reduced from £1,000,000 to £400,000; and 2) the latest date on which any Convertible Loan Notes in issue, together with accrued interest, will be redeemable has been extended from 21 June 2026 to 12 February 2028 (the "New Redemption Date").

 

The Convertible Loan Notes shall automatically convert, in part or in full, at any time from the date of issue until the New Redemption Date, into fully paid ordinary shares in the Company at a price of £1.30 per Share on written notice of the Noteholder. Interest shall be payable on any outstanding Convertible Loan Notes at a rate expected to be 10% - 15% per annum (subject to changing market rates) calculated based on a 365-day year and the actual number of days elapsed from the date of issue of the Convertible Loan Notes to the New Redemption Date.

 

The Investment Manager is a related party of the Company pursuant to the rules of the Aquis Stock Exchange. The independent directors of the Company, having exercised reasonable care, skill and diligence believe that the extension of the Convertible Loan Notes is fair and reasonable as far as the shareholders of the Company are concerned.

 

SuperSeed Capital Limited

Condensed Statement of Comprehensive Income

for the year 1 January 2025 to 31 December 2025

1 October 2025

 

1 January 2025

 

1 January 2025

 

1 January 2024

 

to

 

to

 

to

 

to

 

31 December 2025

 

30 September 2025

 

31 December 2025

 

31 December 2024

 

£

 

£

 

£

 

£

Income

 

 

Realised gain on investments held at fair value through profit or loss

136,198

39,285

175,483

114,032

Unrealised gain on investments held at fair value through profit or loss

204,882

72,152

277,034

322,505

Other income

112

294

406

3,740

Total income

 

341,192

 

111,731

 

452,923

 

440,277

 

Expenses

 

 

Administration fees

7,842

23,529

31,371

32,406

Audit fees

7,251

18,699

25,950

25,000

Directors' fees

5,000

15,000

20,000

20,000

Insurance

-

1,036

1,036

1,036

Legal & professional fees

9,939

30,147

40,086

47,118

Loan interest

11,987

27,968

39,955

7,878

Management fees

2,003

6,010

8,013

7,053

Regulatory fees

3,563

12,238

15,801

16,813

Sundry expenses

-

93

93

1,102

Total expenses

 

47,585

 

134,720

 

182,305

 

158,406

 

Total gain / (loss) and comprehensive income / (loss) for the period

 

293,607

(22,989)

 

270,618

 

281,871

 

 

Basic earnings per share

 

0.1241

 

(0.0097)

 

0.1144

 

0.1192

 

Diluted earnings per share

 

0.1241

 

(0.0097)

 

0.1144

 

0.1167

 

All the above items are derived from continuing operations.

 

 

 

SuperSeed Capital Limited

Condensed Statement of Financial Position

as at 31 December 2025

31 December 2025

 

30 September 2025

 

31 December 2024

 

£

 

£

 

£

 

Non-current assets

 

Investments

3,292,621

3,487,962

3,050,658

Total non-current assets

3,292,621

 

3,487,962

 

3,050,658

 

Current assets

 

Trade and other receivables

7,318

6,109

7,417

Cash and cash equivalents

36,062

29,759

27,870

Total current assets

43,380

 

35,868

 

35,287

 

Total assets

3,336,001

3,523,830

3,085,945

Current liabilities

 

Trade and other payables

47,499

38,121

43,403

Loans payable

50,402

541,216

75,060

Total current liabilities

97,901

 

579,337

 

118,463

 

Total liabilities

97,901

579,337

118,463

Net assets

3,238,100

 

2,944,493

 

2,967,482

 

Equity

 

Share capital

2,369,743

2,369,743

2,369,743

Retained earnings

868,357

574,750

597,739

Total equity

3,238,100

 

2,944,493

 

2,967,482

 

Net asset value per ordinary share

1.3688

 

1.2447

 

1.2544

 

Net asset value per ordinary share inclusive of notional management fee*

1.3325

1.2084

1.2179

*In accordance with Section 13.1.2 of the Alternative Investment Management Agreement between the Company and SuperSeed Ventures LLP (the "Manager") dated 21 January 2022, the Manager is entitled to receive from the Company a management fee of 20% of the aggregate net realised profits on investments, provided that no fee shall be payable in connection with any investment in respect of which the Manager already receives a fee. If all assets were to be realised at the current valuation, the Manager would be due management fees in the amount of £85,928.

 

 

 

 

SuperSeed Capital Limited

Condensed Statement of Changes in Equity

for the year 1 January 2025 to 31 December 2025

Share Capital

 

Retained Earnings

 

Total

 

£

 

£

 

£

 

Balance as at 1 January 2025

2,369,743

597,739

2,967,482

Total comprehensive income for the year

-

270,618

270,618

Balance as at 31 December 2025

 

2,369,743

 

868,357

 

3,238,100

 

 

 

SuperSeed Capital Limited

Condensed Statement of Cash Flows

for the year 1 January 2025 to 31 December 2025

1 October 2025

 

1 January 2025

 

1 January 2024

 

to

 

to

 

to

 

 

31 December 2025

 

31 December 2025

 

31 December 2024

 

£

 

£

 

£

Cash flows used in operating activities

 

 

Net cash flow used in operating activities

 

(27,317)

(137,749)

(136,662)

 

 

Cash flows from / (used in) investing activities

 

Net cash flow from / (used in) investing activities

536,421

210,554

(1,835)

Cash flows (used in) / from financing activities

 

Net cash flow (used in) / from financing activities

(502,801)

(64,613)

67,182

 

Net movement in cash and cash equivalents during the period

6,303

8,192

(71,315)

 

Cash and cash equivalents at the beginning of the period

29,759

27,870

99,185

 

Cash and cash equivalents at the end of the period

36,062

 

36,062

 

27,870

 

 

 

 

SuperSeed Capital Limited

Investment Analysis

for the year 1 January 2025 to 31 December 2025

31 December 2025

 

31 December 2024

 

£

 

£

 

Cost

2,135,128

2,170,199

Cumulative movement in value

1,157,493

880,459

Fair value

3,292,621

 

3,050,658

 

 

Investment fair value can be further analysed as follows:

 

 

1 October 2025

 

1 January 2025

 

1 January 2024

 

to

 

to

 

to

 

31 December 2025

 

31 December 2025

 

31 December 2024

 

£

 

£

 

£

Cost

Cost at beginning of the period

2,535,351

2,170,199

1,875,058

Cost of investment - settled

238,511

770,794

905,788

Cost of investment - sold

(638,734)

(805,865)

(610,647)

Total cost of investment

2,135,128

2,135,128

2,170,199

Fair value movement

Fair value adjustment at beginning of the period

952,611

880,459

557,954

Revaluation of underlying investments

204,882

277,034

322,505

1,157,493

1,157,493

880,459

Fair value of investments

3,292,621

 

3,292,621

 

3,050,658

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBUGDDUXBDGLD
Date   Source Headline
22nd May 20267:00 amRNSRelated Party Transaction
20th May 20267:00 amRNSQ1 2026 Results
13th Apr 20267:00 amRNSRelated Party Transaction
1st Apr 20267:00 amRNSRelated Party Transaction
30th Mar 20267:00 amRNSFinal Results For The Year Ended 31 December 2025
13th Feb 20267:00 amRNSQ4 2025 Results
10th Feb 20267:00 amRNSRelated Party Transaction
19th Jan 20267:00 amRNSRelated Party Transaction
2nd Dec 20257:00 amRNSRelated Party Transaction
24th Nov 20257:00 amRNSQ3 2025 Results
18th Nov 20257:00 amRNSRelated Party Transaction
4th Nov 20257:00 amRNSRelated Party Transaction
10th Oct 20258:58 amRNSRelated Party Transaction
29th Aug 20257:00 amRNSInterim Results for Q2 and H1 2025
26th Aug 20257:00 amRNSRelated Party Transaction
17th Jul 20257:00 amRNSRelated Party Transaction
26th Jun 20257:00 amRNSResults of third AGM
5th Jun 20257:00 amRNSNotice of Third AGM
4th Jun 20257:00 amRNSQ1 2025 Results
29th May 20252:45 pmRNSRelated Party Transaction
14th May 20257:00 amRNSFinal Results for the year ended 31 December 2024
21st Mar 20257:00 amRNSRelated Party Transaction
6th Mar 20257:00 amRNSUnaudited Q4 2024 Results
14th Feb 20257:00 amRNSRelated Party Transaction
23rd Jan 202510:18 amRNSRelated Party Transaction
16th Dec 20243:00 pmRNSRelated Party Transaction
20th Nov 20247:00 amRNSQ3 and 9-months ending 30 September 2024 results
11th Oct 20247:00 amRNSRelated Party Transaction
12th Sep 202411:36 amRNSRelated Party Transaction
6th Sep 20247:00 amRNSInterim Results for Q2 and H1 2024
24th Jun 20247:00 amRNSIssuance of warrants and extension of CLNs
18th Jun 20247:00 amRNSRelated party transaction
14th Jun 20247:00 amRNSResults of second AGM
31st May 20247:00 amRNSQ1 2024 Results
29th May 20247:00 amRNSNotice of Second Annual General Meeting
23rd May 20247:00 amRNSFinal results for the year ended 31 December 2023
28th Mar 202412:50 pmRNSIssue of Convertible Loan Notes
11th Mar 20247:00 amRNSUnaudited Q4 2023 Results
13th Feb 20241:17 pmRNSRelated party transaction - issue of CLNs
22nd Nov 20237:00 amRNSQ3 AND NINE MONTHS TO 30 SEPTEMBER 2023 RESULTS
17th Nov 20233:00 pmRNSCORRECTION TO Q2 AND HALF YEAR RESULTS
18th Sep 20237:00 amRNSSale of Garvis
16th Aug 20237:00 amRNSQ2 Interim Results & Half Year Ending June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.